Renaissance Technologies LLC Reduces Stock Holdings in Transcat, Inc. $TRNS

Renaissance Technologies LLC reduced its position in shares of Transcat, Inc. (NASDAQ:TRNS) by 63.6% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 34,700 shares of the scientific and technical instruments company’s stock after selling 60,500 shares during the period. Renaissance Technologies LLC’s holdings in Transcat were worth $2,549,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently bought and sold shares of the company. Wellington Management Group LLP grew its stake in shares of Transcat by 677.7% in the 4th quarter. Wellington Management Group LLP now owns 248,539 shares of the scientific and technical instruments company’s stock valued at $14,100,000 after buying an additional 216,579 shares during the period. First Eagle Investment Management LLC purchased a new stake in shares of Transcat during the 4th quarter valued at approximately $7,259,000. King Luther Capital Management Corp raised its position in shares of Transcat by 182.3% during the 4th quarter. King Luther Capital Management Corp now owns 103,750 shares of the scientific and technical instruments company’s stock valued at $5,886,000 after buying an additional 67,000 shares during the period. Royce & Associates LP lifted its holdings in Transcat by 15.3% in the fourth quarter. Royce & Associates LP now owns 390,546 shares of the scientific and technical instruments company’s stock valued at $22,156,000 after acquiring an additional 51,774 shares during the last quarter. Finally, ArrowMark Colorado Holdings LLC lifted its holdings in Transcat by 56.7% in the fourth quarter. ArrowMark Colorado Holdings LLC now owns 133,738 shares of the scientific and technical instruments company’s stock valued at $7,587,000 after acquiring an additional 48,367 shares during the last quarter. 98.34% of the stock is currently owned by institutional investors and hedge funds.

Trending Headlines about Transcat

Here are the key news stories impacting Transcat this week:

• Positive Sentiment: Transcat’s latest quarterly results exceeded expectations, with earnings of $0.51 per share versus the $0.38 consensus estimate and revenue of $92.95 million compared with expectations of $86.55 million. This indicates solid operating momentum, although the results are not the primary focus of today’s trading. TRNS Q2 deep dive: Service segment drives growth, margin pressures persist
• Neutral Sentiment: Northland’s $95 price target and “Market Perform” rating indicate a neutral stance rather than a bullish or bearish recommendation. Transcat Rating Lowered to Market Perform at Northland Securities
• Negative Sentiment: Northland cut its Q3 2027 EPS forecast to $0.20 from $0.38 and lowered FY2027 EPS to $1.71 from $1.86. It also reduced estimates for FY2028 to $2.12 from $2.33, FY2029 to $2.58 from $3.18, and FY2030 to $3.01 from $3.51.
• Negative Sentiment: The firm additionally lowered Q2 2027 EPS to $0.41 from $0.45, Q4 2027 EPS to $0.60 from $0.62, and FY2031 EPS to $3.53 from $3.88. The broad-based reductions imply weaker-than-previously-expected earnings growth and are likely weighing on the stock.
• Negative Sentiment: Transcat trades at a very elevated valuation, with a trailing P/E above 250. Downward revisions therefore create greater downside sensitivity, particularly while the stock is near its 52-week high.

Analysts Set New Price Targets

Several brokerages recently weighed in on TRNS. Northland Securities lowered Transcat from an “outperform” rating to a “market perform” rating and set a $95.00 price objective for the company. in a research report on Wednesday, August 5th. Zacks Research raised Transcat from a “strong sell” rating to a “hold” rating in a research note on Friday, May 15th. Wall Street Zen upgraded Transcat from a “sell” rating to a “hold” rating in a report on Sunday, June 28th. Finally, Weiss Ratings raised Transcat from a “sell (d)” rating to a “sell (d+)” rating in a research report on Thursday, May 28th. One investment analyst has rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, Transcat has a consensus rating of “Hold” and a consensus target price of $105.50.

Transcat Stock Performance

Shares of TRNS stock opened at $93.11 on Monday. The company has a debt-to-equity ratio of 0.36, a quick ratio of 2.11 and a current ratio of 2.49. The firm has a market cap of $871.51 million, a P/E ratio of 251.65 and a beta of 0.68. The firm’s 50 day moving average price is $89.60 and its 200-day moving average price is $79.73. Transcat, Inc. has a one year low of $50.23 and a one year high of $96.60.

Transcat (NASDAQ:TRNS) last posted its earnings results on Tuesday, August 4th. The scientific and technical instruments company reported $0.51 earnings per share for the quarter, beating the consensus estimate of $0.38 by $0.13. The firm had revenue of $92.95 million during the quarter, compared to the consensus estimate of $86.55 million. Transcat had a net margin of 0.99% and a return on equity of 5.56%. As a group, equities research analysts predict that Transcat, Inc. will post 1.74 EPS for the current year.

Transcat Company Profile

Transcat, Inc (NASDAQ: TRNS) is a leading provider of calibration, laboratory, and metrology services in North America. Founded in 1964 and headquartered in Ronkonkoma, New York, the company specializes in ensuring the accuracy and compliance of measurement instruments across a wide range of industries. Transcat operates a network of ISO/IEC 17025–accredited laboratories and offers on-site field calibration, instrument repair, and preventive maintenance services.

In addition to its calibration services, Transcat distributes precision instrumentation and related software solutions from top manufacturers.